Insulet (PODD) total liabilities

Total liabilities · fiscal 2025
$1.68B

Insulet (PODD) had total liabilities of $1.68B at the end of fiscal 2025 (December 31, 2025). That is 10.7% lower than the $1.88B of fiscal 2024. Figures as of 18 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$1.68B
Change on fiscal 2024
−10.7%
Growth, 5 years
+5.7% a year
Growth, 10 years
+21.4% a year
Highest on record
$1.88Bfiscal 2024
Lowest on record
$90.00Mfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Insulet total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 5.7% a year; over ten years the rate was 21.4% a year. Across the 16 fiscal years on record (2010–2025), the highest was $1.88B in fiscal 2024 and the lowest $90.00M in fiscal 2010.

History · 16 fiscal years

Total liabilities by fiscal year

Insulet total liabilities, year by year

Insulet (PODD) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$1.68B 10.7% down
2024$1.88B 1.1% up
2023$1.86B 4.6% up
2022$1.77B 18.9% up
2021$1.49B 17.6% up
2020$1.27B 19.0% up
2019$1.07B 48.9% up
2018$716.60M 8.9% up
2017$658.23M 67.3% up
2016$393.50M 63.2% up
2015$241.08M 13.0% up
2014$213.35M 30.6% up
2013$163.36M 6.2% up
2012$153.88M 11.0% up
2011$138.59M 54.0% up
2010$90.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Insulet and comparable companies
CompanyTotal liabilitiesFiscal year
Vaxcyte PCVX$317.21M2025
Bio-Rad Laboratories BIO$3.12B2025
Molina Healthcare MOH$11.50B2025
Spyre Therapeutics SYRE$62.55M2025
Qiagen QGEN$2.50B2025
Insulet PODD$1.68B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PODD

Insulet, figure by figure

Insulet (PODD) overview: price, valuation and scorecardAll health care companies by market value

Insulet total liabilities: questions and answers

How large are Insulet's total liabilities?

Insulet (PODD) had total liabilities of $1.68B at the end of fiscal 2025 (December 31, 2025). That is 10.7% lower than the $1.88B of fiscal 2024.

What is the growth rate of Insulet's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 5.7% a year; over ten years the rate was 21.4% a year.

What are the highest and lowest total liabilities figures on record for Insulet?

Across the 16 fiscal years on record (2010–2025), the highest was $1.88B in fiscal 2024 and the lowest $90.00M in fiscal 2010.

How is Insulet's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Insulet it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Insulet (PODD) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/PODD/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.